Immunome, Inc.IMNMNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
29.98%
↑ 144% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-68.77%
Historical baseline
PeriodValue
202529.98%
2024-179.19%
2023-196.82%
2022-46.41%
2021-105.56%
2020-18.49%
2019-33.64%
20180.00%